Search for the best prices     on the Internet!

Table of Contents:

List of principal contributors
1 The impact of the genomic revolution on gynecological endocrinology 1
2 Evaluation and therapy of postmenarcheal menstrual disorders 5
3 Hormonal substitution in young women with gonadal dysgenesis 9
4 Adrenal dysfunction evaluation and hyperandrogenic states in young postpubertal patients 13
5 Differential steroidogenic effect of pituitary hormones in primate corpus luteum 21
6 Does a genetic factor cause increased thecal androgen secretion in polycystic ovary syndrome? 25
7 Polycystic ovary disease: heritability and heterogeneity 33
8 Physiopathology of hyperinsulinemia in polycystic ovary syndrome 39
9 Weight loss and insulin-sensitizers in the treatment of polycystic ovary syndrome 45
10 New insights into polycystic ovary syndrome by color Doppler, three-dimensional ultrasound and vascular endothelial growth factor 57
11 Relationship between hyperandrogenism and disorders of glucose metabolism and uterine perfusion 63
12 The effect of a herbal treatment (Tian Gui) for polycystic ovary syndrome of the hyperinsulinemic pattern 67
13 Ovulation induction in polycystic ovary syndrome patients 79
14 Transdermal estrogens for the treatment of premenstrual syndrome 83
15 Epidemiology and psychosocial aspects of premenstrual syndrome in Italy 91
16 Hormonal methods of emergency contraception 95
17 Benefits of injectable contraception to women's health 101
18 Immunobiology of endometriosis: molecular aspects and local cytokines 107
19 Peritoneal endometriosis, ovarian endometriosis and adenomyotic nodules of the rectovaginal septum: three different entities which require a specific therapy 113
20 Angiogenesis and endometriosis 121
21 ART in patients with endometriosis 127
22 Endocrine regulation of tubal function 131
23 Premature ovarian failure: an autoimmune disease? 143
24 Preservation of fertility and ovarian function and minimalization of chemotherapy-associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers 151
25 Uterine fibroids and infertility: what strategy of management? 169
26 Surgical approaches to uterine myomas 173
27 Regulation of fetal allograft survival by hormone-controlled T cell cytokines 177
28 Subset distribution and proliferative response of peripheral blood T cells from patients with recurrent spontaneous abortion 181
29 Early pregnancy-promoting actions of luteinizing hormone and human chorionic gonadotropin 185
30 Is there a role for aspirin in recurrent miscarriage? 193
31 Insulin-like growth factor system and fetal growth 201
32 Metabolic and epidemiological evidence of the association between insulin resistance and pre-eclampsia 207
33 Genetics of postmenopausal complications 211
34 Non-transcriptional mechanisms for estrogen receptors signaling 225
35 Assessment of quality of life in the climacteric 235
36 Hormone replacement therapy and lipid profile: effects of different routes of administration 237
37 Effect of DHEA on carbohydrate and lipid metabolism in postmenopausal women 245
38 DHEA replacement therapy as a source of androgens and estrogens at menopause 249
39 Long-term testosterone replacement therapy with slow-release silastic implants 259
40 Delta 5-androgen replacement therapy in postmenopausal women 267
41 Hormone therapy in uterine bleeding disorders and menorrhagia 277
42 Soy and the treatment of menopause 283
43 The validity of diagnostic tests for adnexal mass: a critical analysis 295
44 The secretion of inhibin-related molecules by ovarian tumors 299
45 Inhibin-related proteins and endometrium 303
46 Somatostatin receptors and vascular endothelial growth factor in human breast cancer 307
Index 313